Search results
UTHR vs. ESALY: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 1 year agoInvestors with an interest in Medical - Drugs stocks have likely encountered both United...
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Benzinga via Yahoo Finance· 2 years agoEisai Co Ltd (OTC: ESALY) has completed the rolling submission of the FDA marketing application...
Despite Safety Concerns, Analysts Are Bullish On Biogen's Second Alzheimer's Candidate
Benzinga via Yahoo Finance· 1 year agoEisai Limited (OTC: ESALY) and partner Biogen Inc (NASDAQ: BIIB) presented detailed data from the...
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
Benzinga via Yahoo Finance· 1 year agoEisai Co Ltd (OTC: ESALY) and Biogen Inc (NASDAQ: BIIB) announced that three additional detailed...
Open Questions On Safety Lingers After Eisai-Biogen's Detailed Lecanemab Data For Alzheimer's
Benzinga via Yahoo Finance· 1 year agoAccording to detailed data, Eisai Limited (OTC: ESALY) and Biogen Inc's (NASDAQ: BIIB) closely...
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
Benzinga via Yahoo Finance· 1 year agoThe FDA has accepted Eisai Co Ltd (OTC: ESALY) and Biogen Inc's (NASDAQ: BIIB) supplemental...
Despite Advancement, Benefits From Alzheimer's Drugs May Be Limited, Say Researchers
Benzinga via Yahoo Finance· 2 years agoRecently, Biogen Inc (NASDAQ: BIIB) and Eisai Co (OTC: ESALY) announced encouraging data from the...
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) and Eisai Co Ltd (OTC: ESALY) presented final analysis results from Phase...
This Analyst Believes Biogen's Lecanemab Data Not 'Slam Dunk' For Complete CMS Approval
Benzinga via Yahoo Finance· 2 years agoBiogen Inc (NASDAQ: BIIB) and its partner Eisai Limited (OTC: ESALY) announced a significant...
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare...
Benzinga via Yahoo Finance· 10 months agoExperts in Europe considering the potential use of a new Alzheimer's disease drug developed by Eisai...